Skip to main content Accessibility help

We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.

Close cookie message
×
Hostname: page-component-77c89778f8-rkxrd Total loading time: 0 Render date: 2024-07-18T01:25:20.830Z Has data issue: false hasContentIssue false

Chapter 7 - Drugs in Women with Renal Disease and Transplant Recipients in Pregnancy

from Section 3 - Antenatal Care

Published online by Cambridge University Press:  19 May 2018

By
Graham Lipkin ,
Asif Sarwar  and
Ellen Knox
Edited by
Kate Bramham ,
Matt Hall  and
Catherine Nelson-Piercy
Kate Bramham
Affiliation:
King’s College Hospital, London
Matt Hall
Affiliation:
Nottingham University Hospitals
Catherine Nelson-Piercy
Affiliation:
Guys's & St Thomas's NHS Foundation Trust, London
Get access

Summary

A summary is not available for this content so a preview has been provided. Please use the Get access link above for information on how to access this content.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Chapter
Information
Renal Disease in Pregnancy , pp. 70 - 86
Publisher: Cambridge University Press
Print publication year: 2018

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

McCarthy, M. Use of prescription drugs is common during pregnancy, US study finds. BMJ 2015; 351: h4421.Google Scholar
Briggs, GG, Freeman, RK, Yaffe, SJ. Drugs in pregnancy and lactation: A reference guide to fetal and neonatal risk. 7th edn. Philadelphia, PA; London: Lippincott Williams & Wilkins, 2005.Google Scholar
Koren, G, Pastuszak, A, Ito, S. Drugs in pregnancy. N Engl J Med 1998; 338(16): 1128–1137.CrossRefGoogle ScholarPubMed
Garbis, H, Elefant, E, Diav-Citrin, O, Mastroiacovo, P, Schaefer, C, Vial, T, et al. Pregnancy outcome after exposure to ranitidine and other H2-blockers: A collaborative study of the European Network of Teratology Information Services. Reprod Toxicol 2005; 19(4): 453–458.Google Scholar
McKay, DB, Josephson, MA. Pregnancy in recipients of solid organs – effects on mother and child. N Engl J Med 2006; 354(12): 1281–1293.CrossRefGoogle ScholarPubMed
Fischer, MJ. Chronic kidney disease and pregnancy: Maternal and fetal outcomes. Adv Chronic Kidney Dis 2007; 14(2): 132–145.Google Scholar
Levey, AS, Bosch, JP, Lewis, JB, Greene, T, Rogers, N, Roth, D. A more accurate method to estimate glomerular filtration rate from serum creatinine: A new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 1999; 130(6): 461–470.CrossRefGoogle ScholarPubMed
Watnick, S, Rueda, J. Reproduction and contraception after kidney transplantation. Current Opinion in Obstetrics and Gyneacology 2008; 19(3): 308–318.CrossRefGoogle Scholar
Deshpande, NA et al. Pregnancy outcomes in kidney transplant recipients: A systematic review and meta-analysis. American Journal of Transplantation 2011; 11(11): 2388–2404.Google Scholar
European Best Practice Guidelines for Renal Transplantation. Section IV: Long-Term Management of the Transplant Recipient. IV.10. Pregnancy in renal transplant recipients. Nephrol Dial Transplant 2002; 17 Suppl. 4: 50–55.Google Scholar
Götestam Skorpen, C, et al. The EULAR points to consider for use of antirheumatic drugs before pregnancy, and during pregnancy and lactation. Annals of the Rheumatic Diseases 2016; 75: 795–810.Google Scholar
Park-Wyllie, L, et al. Birth defects after maternal exposure to corticosteroids: Prospective cohort study and meta-analysis of epidemiological studies. Teratology 2000; 62(6): 385–392.Google Scholar
Hviid, A, Molgaarg-Nielsen, D. Corticosteroid use during pregnancy and risk of orofacial clefts. Canadian Medical Association Journal 2011; 183(7): 796–804.Google Scholar
Hou, S. Pregnancy in chronic renal insufficiency and end-stage renal disease. Am J Kidney Dis 1999; 33(2): 235–252.CrossRefGoogle ScholarPubMed
Empson, M, Lassere, M, Craig, J, Scott, J. Prevention of recurrent miscarriage for women with antiphospholipid antibody or lupus anticoagulant. Cochrane Database Syst Rev 2005; (2): CD002859.Google Scholar
Ostensen, M, Khamashta, M, Lockshin, M, Parke, A, Brucato, A, Carp, H, et al. Anti-inflammatory and immunosuppressive drugs and reproduction. Arthritis Res Ther 2006; 8(3): 209.CrossRefGoogle ScholarPubMed
Armenti, VT, Radomski, JS, Moritz, MJ, Philips, LZ, McGrory, CH, Coscia, LA. Report from the National Transplantation Pregnancy Registry (NTPR): Outcomes of pregnancy after transplantation. Clin Transpl 2000; 123–134.Google Scholar
Greenberger, PA, Odeh, YK, Frederiksen, MC, Atkinson, AJ Jr. Pharmacokinetics of prednisolone transfer to breast milk. Clin Pharmacol Ther 1993; 53(3): 324–328.CrossRefGoogle ScholarPubMed
Saarikoski, S, Seppala, M. Immunosuppression during pregnancy: Transmission of azathioprine and its metabolites from the mother to the fetus. Am J Obstet Gynecol 1973; 115(8): 1100–1106.CrossRefGoogle ScholarPubMed
Chambers, CD, Tutuncu, ZN, Johnson, D, Jones, KL. Human pregnancy safety for agents used to treat rheumatoid arthritis: Adequacy of available information and strategies for developing post-marketing data. Arthritis Res Ther 2006; 8(4): 215.Google Scholar
Davison, JM, Dellagrammatikas, H, Parkin, JM. Maternal azathioprine therapy and depressed haemopoiesis in the babies of renal allograft patients. Br J Obstet Gynaecol 1985; 92(3): 233–239.Google Scholar
Armenti, VT, Ahlswede, KM, Ahlswede, BA, Jarrell, BE, Moritz, MJ, Burke, JF. National Transplantation Pregnancy Registry – outcomes of 154 pregnancies in ciclosporine-treated female kidney transplant recipients. Transplantation 1994; 57(4): 502–506.CrossRefGoogle ScholarPubMed
Sibanda, N, Briggs, JD, Davison, JM, Johnson, RJ, Rudge, CJ. Pregnancy after organ transplantation: A report from the UK Transplant Pregnancy Registry. Transplantation 2007; 83(10): 1301–1307.Google Scholar
McKay, DB, Josephson, MA, Armenti, VT, August, P, Coscia, LA, Davis, CL, et al. Reproduction and transplantation: Report on the AST Consensus Conference on Reproductive Issues and Transplantation. Am J Transplant 2005; 5(7): 1592–1529.CrossRefGoogle ScholarPubMed
Sau, A, Clarke, S, Bass, J, Kaiser, A, Marinaki, A, Nelson-Piercy, C. Azathioprine and breastfeeding: Is it safe? Bjog 2007; 114(4): 498–501.CrossRefGoogle ScholarPubMed
Christensen, LA, Dahlerup, JF, Nielsen, M, Fallingborg, J, Schmiegelow, K. Azathioprine treatment during lactation. Ailment Pharmacol Ther 2008; 28: 1209–1213.CrossRefGoogle ScholarPubMed
Venkataramanan, R, Koneru, B, Wang, CC, Burckart, GJ, Caritis, SN, Starzl, TE. Ciclosporine and its metabolites in mother and baby. Transplantation 1988; 46(3): 468–469.Google Scholar
Bar Oz, B, Hackman, R, Einarson, T, Koren, G. Pregnancy outcome after ciclosporine therapy during pregnancy: A meta-analysis. Transplantation 2001; 71(8): 1051–1055.CrossRefGoogle ScholarPubMed
Satchell, S, Moppett, J, Quinn, M, Nicholls, A. Pregnancy, tacrolimus, and renal transplantation: Survival of a 358-g baby (letter). Nephrol Dial Transplant 2000; 15(12): 2065–2066.Google Scholar
Hebert, M, Zheng, S, Hays, K, Shen, D, Davis, C, Umans, J, Miodovnik, M, Thummel, K, Easterling, T. Interpreting tacrolimus concentrations during pregnancy and postpartum. Transplantation 2013; 95(7): 908–915.Google Scholar
Armenti, VT, Radomski, JS, Moritz, MJ, Gaughan, WJ, Hecker, WP, Lavelanet, A, et al. Report from the National Transplantation Pregnancy Registry (NTPR): Outcomes of pregnancy after transplantation. Clin Transpl 2004: 103–114.Google Scholar
Fischer, T, Neumayer, HH, Fischer, R, Barenbrock, M, Schobel, HP, Lattrell, BC, et al. Effect of pregnancy on long-term kidney function in renal transplant recipients treated with ciclosporine and with azathioprine. Am J Transplant 2005; 5(11): 2732–2739.CrossRefGoogle ScholarPubMed
Zheng, S, Easterling, T, Umans, J, Miodovnik, M, Calamia, J, Thummel, K, Shen, D, Davis, C, Herbert, M. Pharmacokinetics of tacrolimus during pregnancy. Ther Drug Monit 2012; 34(6): 660–670.CrossRefGoogle ScholarPubMed
Day, C, Hewins, P, Sheikh, L, Kilby, M, McPake, D, Lipkin, G. Cholestasis in pregnancy associated with ciclosporin therapy in renal transplant recipients. Transpl Int 2006; 19(12): 1026–1029.Google Scholar
Ono, E, et al. Immunophenotypic profile and increased risk of hospital admission for infection in infants born to female kidney transplant recipients. American Journal of Transplantation; 15(6): 1654–1665.Google Scholar
Stanley, CW, Gottlieb, R, Zager, R, Eisenberg, J, Richmond, R, Moritz, MJ, et al. Developmental well-being in offspring of women receiving ciclosporine post-renal transplant. Transplant Proc 1999; 31(1–2): 241–242.Google Scholar
Tendron-Franzin, A, Gouyon, JB, Guignard, JP, Decramer, S, Justrabo, E, Gilbert, T, et al. Long-term effects of in utero exposure to cyclosporin A on renal function in the rabbit. J Am Soc Nephrol 2004; 15(10): 2687–2693.CrossRefGoogle ScholarPubMed
Giudice, PL, Dubourg, L, Hadj-Aissa, A, Said, MH, Claris, O, Audra, P, et al. Renal function of children exposed to cyclosporin in utero. Nephrol Dial Transplant 2000; 15(10): 1575–1579.Google Scholar
Munoz-Flores-Thiagarajan, KD, Easterling, T, Davis, C, Bond, EF. Breast-feeding by a ciclosporine-treated mother. Obstet Gynecol 2001; 97(5 Pt 2): 816–818.Google Scholar
Moretti, ME, Sgro, M, Johnson, DW, Sauve, RS, Woolgar, MJ, Taddio, A, et al. Ciclosporine excretion into breast milk. Transplantation 2003; 75(12): 2144–2146.CrossRefGoogle ScholarPubMed
Lahiff, C, Moss, A. Ciclosporine in the management of severe ulcerative colitis while breast-feeding. Inflamm Bowel Dis 2011; 17(7): E78.Google Scholar
Osadchy, A, Koren, G. Ciclosporine and lactation: When the mother is willing to breastfeed. Ther Drug Monit 2011; 33(2): 147–148.Google Scholar
Bramham, K, Chusney, G, Lee, J, Lightstone, L, Nelson-Piercy, C. Breastfeeding and tacrolimus: Serial monitoring in breast-fed and bottle-fed infants. Clin J Am Soc Nephrol 2013; 8(4): 563–567.Google Scholar
D’Cruz, DP, Khamashta, MA, Hughes, GR. Systemic lupus erythematosus. Lancet 2007; 369(9561): 587–596.CrossRefGoogle ScholarPubMed
Tjeertes, IF, Bastiaans, DE, van Ganzewinkel, CJ, Zegers, SH. Neonatal anemia and hydrops fetalis after maternal mycophenolate mofetil use. J Perinatol 2007; 27(1): 62–64.Google Scholar
Hoeltzenbein, M, Elefant, E, Vial, T, Finkel‐Pekarsky, V, Stephens, S, Clementi, M, Allignol, A, Weber-Schoendorfer, C, Schaefer, C. Teratogenicity of mycophenolate confirmed in a prospective study of the European Network of Teratology Information Services. Am J Med Genet 2012; Part A; 158(3): 588–596.Google Scholar
Jones, A, Clary, M, McDermott, E, Coscia, L, Constantinescu, S, Moritz, M, Armenti, V. Outcomes of pregnancies fathered by solid-organ transplant recipients exposed to mycophenolic acid products. Prog Transplant 2013; 23(2): 153–157.Google Scholar
Medicines and Healthcare Products Regulatory Agency. Drug Safety Update: Mycophenolate mofetil, mycophenolic acid new pregnancy-prevention advice for women and men. Published December 14, 2015. www.gov.uk/drug-safety-update/mycophenolate-mofetil-mycophenolic-acid-new-pregnancy-prevention-advice-for-women-and-men.Google Scholar
Hall, M, et al. Recommendations for men taking mycophenolate derivatives and pregnancy following MHRA recommendations. Published November 5, 2016. www.renal.org/docs/default-source/default-document-library/mycophenolate-and-fathers-to-be-letter-may-2016da90a131181561659443ff000014d4d8.pdf?sfvrsn=0.Google Scholar
Zuber, J, Anglicheau, D, Elie, C, Bererhi, L, Timsit, M, Mamzer-Bruneei, L, Ciroldi, M, Martinez, F, Snanoudj, R, Hiesse, C, Kreis, Eustach F, Laborde, K, Thervet, E, Legendre, C. Sirolimus may reduce fertility in male renal transplant recipients. Am J Transplant 2008; 8(7): 1471–1479.CrossRefGoogle ScholarPubMed
Braun, M. et al. Ovarian toxicity from sirolimus. N Engl J Med 2012; 366: 1062–1064.Google Scholar
Coscia, L, Constantinescu, S, Moritz, M, Frank, A, Ramirez, C, Maley, W, Doria, C, McGrory, C, Armenti, V. Report from the National Transplantation Pregnancy Registry (NTPR): Outcomes of pregnancy after transplantation. Los Angeles. Clinical Transplants, 2010; 65–85.Google Scholar
Sifontis, NM, Coscia, LA, Constantinescu, S, Lavelanet, AF, Moritz, MJ, Armenti, VT. Pregnancy outcomes in solid organ transplant recipients with exposure to mycophenolate mofetil or sirolimus. Transplantation 2006; 82(12): 1698–1702.Google Scholar
Valente, JF, Hricik, D, Weigel, K, Seaman, D, Knauss, T, Siegel, CT, et al. Comparison of sirolimus vs. mycophenolate mofetil on surgical complications and wound healing in adult kidney transplantation. Am J Transplant 2003; 3(9): 1128–1134.Google Scholar
Roos, S, Jansson, N, Palmberg, I, Saljo, K, Powell, TL, Jansson, T. Mammalian target of rapamycin in the human placenta regulates leucine transport and is down-regulated in restricted fetal growth. J Physiol 2007; 582(Pt 1): 449–459.CrossRefGoogle ScholarPubMed
Ton, E, Tekstra, J, Hellmann, P, Nuver-Zwart, I, Bijlsma, J. Safety of rituximab therapy during twins’ pregnancy. Rheumatology 2011; 50(4): 806–808.CrossRefGoogle ScholarPubMed
Brian, L, Jentoft, M, Porrata, L, Boyce, T, Witzig, T. Single-agent rituximab for primary CNS lymphoma during pregnancy as a bridge to definitive management. Journal of Clin Oncol 2014; 32(7): e14–e17.Google Scholar
Chakraverty, E, Murray, E, Kelman, A, Farmer, P. Pregnancy outcomes after maternal exposure to rituximab. Blood 2011; 117(5): 1499–1506.Google Scholar
Ardissino, G, Ossola, M, Baffero, G, Rigotti, A, Cugno, M. Eculizumab for atypical hemolytic uremic syndrome in pregnancy. Obstet Gyneacol 2013; 122(2): 487–489.Google Scholar
Mussoni, M, Veneziano, A, Boetti, L, Tassi, C, Calisesi, C, Nucci, S, Rigotto, A, Panzini, I, Ardissino, G. Innovative therapeutic approach: Sequential treatment with plasma exchange and eculizumab in a pregnant woman affected by atypical hemolytic-uremic syndrome. Transfus Apher Sci 2014; 51(2): 134–136.CrossRefGoogle Scholar
Kelly, R et al. Eculizumab in pregnant patients with paroxysmal nocturnal haemoglobulinuria. New England Journal of Medicine 2015; 373: 1032–1039.Google Scholar
Cassina, M, Johnson, D, Robinson, L, Braddock, S, Xu, R, Jiminez, J, Mirrasoul, N, Salas, E, Luo, Y, Jones, K, Chambers, C. Pregnancy outcome in women exposed to leflunomide before or during pregnancy. Arthritis Rheum 2012; 64(7): 2085–2094.Google Scholar
Chambers, C, Johnson, D, Robinson, L, Braddock, S, Xu, R, Lopez-Jimenez, J, Mirrasoul, N, Salas, E, Luo, Y, Jin, S, Jones, K. Organisations of Teratology Information Specialists Collaborative Research Group: Birth outcomes in women who have taken leflunomide during pregnancy. Arthritis Rheum 2010; 62: 1494–1503.Google Scholar
Milman, N, Graudal, N, Nielsen, OJ, Agger, AO. Serum erythropoietin during normal pregnancy: Relationship to hemoglobin and iron status markers and impact of iron supplementation in a longitudinal, placebo-controlled study on 118 women. Int J Hematol 1997; 66(2): 159–168.Google Scholar
Magee, L, Von Dadelszen, P, Darley, J, Beguin, Y. Erythropoiesis and renal transplant pregnancy. Clin Transplant 2000; 14(2): 127–135.Google Scholar
Schneider, H, Malek, A. Lack of permeability of the human placenta for erythropoietin. J Perinat Med 1995; 23(1–2): 71–76.Google Scholar
Hou, SH. Frequency and outcome of pregnancy in women on dialysis. Am J Kidney Dis 1994; 23(1): 60–63.CrossRefGoogle ScholarPubMed
Szurkowski, M, Wiecek, A, Kokot, F, Daniel, K. Safety and efficiency of recombinant human erythropoietin treatment in anemic pregnant women with a kidney transplant. Nephron 1994; 67(2): 242–243.Google Scholar
Okundaye, I, Abrinko, P, Hou, S. Registry of pregnancy in dialysis patients. Am J Kidney Dis 1998; 31(5): 766–764.Google Scholar
Chao, AS, Huang, JY, Lien, R, Kung, FT, Chen, PJ, Hsieh, PC. Pregnancy in women who undergo long-term hemodialysis. Am J Obstet Gynecol 2002; 187(1): 152–156.Google Scholar
Toma, H, Tanabe, K, Tokumoto, T, Kobayashi, C, Yagisawa, T. Pregnancy in women receiving renal dialysis or transplantation in Japan: a nationwide survey. Nephrol Dial Transplant 1999; 14(6): 1511–1516.Google Scholar
Sienas, L, Wong, T, Collins, R, Smith, J. Contemporary uses of erythropoietin in pregnancy: A literature review. Obs and Gyn Survey 2013; 68(8): 594–602.Google Scholar
Kashiwagi, M, Breymann, C, Huch, R, Huch, A. Hypertension in a pregnancy with renal anemia after recombinant human erythropoietin (rhEPO) therapy. Arch Gynecol Obstet 2002; 267(1): 54–56.Google Scholar
Thorp, M, Pulliam, J. Use of recombinant erythropoietin in a pregnant renal transplant recipient. Am J Nephrol 1998; 18(5): 448–451.Google Scholar
Reveiz, L, Gyte, GM, Cuervo, LG. Treatments for iron-deficiency anaemia in pregnancy. Cochrane Database Syst Rev 2007; 2: CD003094.Google Scholar
Al, R, Unlubilgin, E, Kandemir, O, Yalvac, S, Cakir, L, Haberal, A. Intravenous versus oral iron for treatment of anemia in pregnancy: A randomized trial. Obstetrics and Gyneacology 2005; 106(6): 1335–1340.CrossRefGoogle ScholarPubMed
Bhandal, N, Russell, R. Intravenous versus oral therapy for postpartum. BJOG. 2006; 113: 1248–1252.Google Scholar
European Medicines Agency (EMEA). Assessment report for: Iron containing intravenous (IV) medicinal products. [Online] EMEA 2013. www.ema.europa.eu/docs/en_GB/document_library/Referrals_document/IV_iron_31/WC500150771.pdf.Google Scholar
Nadarasa, K, Bailey, M, Chahal, H, Raja, O, Bhat, R, Gayle, C, Grossman, A, Druce, M. The use of cinacalcet in pregnancy to treat a complex case of parathyroid carcinoma. Endocrinol Diabetes Metab Case Rep. 2014; 2014: 140056.Google Scholar
Edling, K, Korenman, S, Janzen, C, Sohsman, M, Apple, S, Bhuta, S, Yeh, M. A pregnant dilemma: Primary hyperparathyroidism due to parathyromatosis in pregnancy. Endocr Pract. 2014; 20(2): e14–7.Google Scholar
Horjus, C, Groot, I, Telting, D, Van Setten, P, Van Sorge, A, Kovacs, C, Hermus, A, de Boer, H. Cinacalcet for hyperparathyroidism in pregnancy and puerperium. J Pediatr Endocrinol Metab. 2009; 22(8): 741–749.Google Scholar
Kenyon, S, Taylor, DJ, Tarnow-Mordi, WO, ORACLE Collaborative Group. ORACLE–antibiotics for preterm prelabour rupture of the membranes: Short-term and long-term outcomes. Acta Paediatr Suppl. 2002; 91(437): 12–15.Google Scholar
Kenyon, S, Boulvain, M, Neilson, JP. Antibiotics for preterm rupture of membranes. Cochrane Database Syst Rev. 2013; 12: CD001058.Google Scholar
Williams, M, Spencer, R. Caesarean section: Summary of updated NICE guidance. BMJ 2011; 343: d7108.Google Scholar
Benyamini, L, Merlob, P, Stahl, B, et al. The safety of amoxicillin/clavulanic acid and cefuroxime during lactation. Ther Drug Monit. 2005; 27: 499–502.Google Scholar
Ben David, S, Einarson, T, Ben David, Y, et al. The safety of nitrofurantoin during the first trimester of pregnancy: Meta-analysis. Fundam Clin Pharmacol 1995; 9: 503–507.CrossRefGoogle ScholarPubMed
Apgar, V: Drugs in pregnancy. JAMA 1964; 190: 840.Google Scholar
Czeizel, AE, Rockenbauer, M, Sorensen, HT, et al. Nitrofurantoin and congenital abnormalities. Eur J Obstet Gynecol Reprod Biol 2001; 95: 119–126.CrossRefGoogle ScholarPubMed
Scottish Intercollegiate Guidelines Network (SIGN): Management of suspected bacterial urinary tract infections in adults. Edinburgh: SIGN, 2012 (SIGN guidance No. 88) [Online]. www.sign.ac.uk.Google Scholar
Pagliaro, LA, Levin, RH: Problems in pediatric drug therapy. Hamilton, IL: Drug Intell Publications, 1979.Google Scholar
Miller, RD, Salter, AJ. The passage of trimethoprim/sulphamethoxazole into breast milk and its significance. Progress in chemotherapy: Proceedings of the Eighth International Congress of Chemotherapy, Athens, 1973, 687–691.Google Scholar
Anon. Committee on Drugs & American Academy of Pediatrics: The transfer of drugs and other chemicals into human milk. Pediatrics 1994; 93, 137–150.Google Scholar
Loebstein, R, Addis, A, Ho, E, et al. Pregnancy outcome following gestational exposure to fluoroquinolones: A multicenter prospective controlled study. Antimicrob Agents Chemother 1998; 42(6): 1336–1339.Google Scholar
Schaefer, C, et al. Pregnancy outcome after prenatal quinolone exposure: evaluation of a case registry of the European Network of Teratology Information Services (ENTIS). European Journal of Obstetrics & Gynecology and Reproductive Biology 1996; 69(2): 83–89.Google Scholar
Harmon, T, Burkhart, G. Perforated pseudomembranous colitis in the breast-fed infant. J Ped Surg 1992; 27(6): 744–746.CrossRefGoogle ScholarPubMed
Yoshida, M, Matsuda, H, Furuya, K. Successful prognosis of brain abscess during pregnancy. J Reprod Infertil. 2013; 14(3): 152–155.Google Scholar

Save book to Kindle

To save this book to your Kindle, first ensure coreplatform@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

Available formats
×